Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AZ, Amgen’s SOURCE trial misses primary endpoint

pharmatimesDecember 23, 2020

Tag: Amgen , Tezepelumab , AstraZeneca , Asthma

PharmaSources Customer Service